After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CTMX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of CytomX Therapeutics Inc is $393.86M. A total of 0.76 million shares were traded on the day, compared to an average of 5.11M shares.
In the most recent transaction, Ogden Christopher sold 10,614 shares of CTMX for 2.69 per share on Jun 16 ’25. After the transaction, the Chief Financial Officer now owns 226,271 company shares. In a previous transaction on Jun 13 ’25, Ogden Christopher sold 1,641 shares at 2.95 per share. CTMX shares that Chief Financial Officer owns now total 199,385.
Among the insiders who sold shares, BELVIN MARCIA disposed of 13,884 shares on Jun 16 ’25 at a per-share price of $2.69. This resulted in the SVP, Chief Scientific Officer holding 272,252 shares of CTMX after the transaction. In another insider transaction, McCarthy Sean A. sold 55,511 shares at $2.69 per share on Jun 16 ’25. Company shares held by the CEO now total 1,089,684.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CTMX has a high of $3.10 and a low of $0.40.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CTMX’s latest balance sheet shows that the firm has $305.23M in Cash & Short Term Investments as of fiscal 2021. There were $21.67M in debt and $77.87M in liabilities at the time. Its Book Value Per Share was $0.31, while its Total Shareholder’s Equity was -$459.00k.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTMX is Buy with a score of 4.43.
